Role of metformin in patients with polycystic ovary syndrome: The state of the art

S. Palomba, A. Falbo, T. Russo, F. Orio, A. Tollino, F. Zullo

Research output: Contribution to journalArticlepeer-review

Abstract

Metformin, an insulin sensitizer widely used for the treatment of patients with type-2 diabetes mellitus (DM), was recentiy introduced in the clinical practice to treat women widi polycystic ovary syndrome (PCOS). The aim of the current review was to evaluate the current role of metformin in the treatment of the PCOS-related disorders. The Authors analyze here the administration of metformin for treating the ovarian dysfunction due to PCOS, and show the evidences available in literature regarding its alternative uses.

Original languageEnglish
Pages (from-to)77-82
Number of pages6
JournalMinerva Ginecologica
Volume60
Issue number1
Publication statusPublished - Feb 2008

Keywords

  • Diabetes mellitus, type 2
  • Metformin
  • Ovulation
  • Polycystic ovary syndrome
  • Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint

Dive into the research topics of 'Role of metformin in patients with polycystic ovary syndrome: The state of the art'. Together they form a unique fingerprint.

Cite this